Category: lipid nanoparticles

Exosomes hold immense potential as vehicles for targeted therapeutic delivery, capable of transporting a diverse range of biomolecules to specific cells. However, a significant challenge lies in stabilizing targeting peptides displayed on exosome surfaces to ensure effective delivery. In a groundbreaking study, researchers at Northwestern University have identified a novel strategy for stabilizing these peptides […]

The realm of bioactive colloidal carrier systems in the nano-range is opening new doors to overcome challenges in treating various diseases. Among these, lipid nanoparticles (LNPs) have emerged as a powerful tool in enhancing the bioavailability, transportation, and stability of encapsulated compounds. LNPs not only improve pharmacokinetics but also enable efficient targeting, reducing the risk […]

In the realm of combating the intricate pathophysiology of COVID-19, the imperative to unravel the pivotal actors orchestrating pulmonary inflammation and fibrosis looms large. Among these actors, the hyperactivation of neutrophils, including the formation of deleterious neutrophil extracellular traps (NETs), stands out as a hallmark of severe COVID-19 cases and potential contributor to long-term complications. […]

Dendritic cells (DCs) play a crucial role in the immune system, being the first responders to threats like viruses and bacteria. These cells determine whether to trigger a calm immune response or a full-blown attack, a decision that has long puzzled researchers. Recently, Belgian scientists have shed light on this process using lipid nanoparticles (LNPs), […]

A groundbreaking study introduces a novel class of “theranostic” nanoparticles designed to detect and mitigate arterial plaques, the underlying cause of heart disease. These nanoparticles, developed by researchers at the South Australian Health and Medical Research Institute (SAHMRI) in collaboration with teams from Toronto, Sydney, and Melbourne, represent a significant advancement in combating heart disease […]

Seychellois nanoliposome delivery systems have emerged as a cutting-edge technology in the field of drug delivery, particularly in applications like monoclonal antibodies and cell therapy. These lipid nanoparticles offer a promising avenue for enhancing the efficacy and safety of therapeutic interventions. By encapsulating drugs within nanoliposomes, researchers can achieve targeted delivery to specific cells or […]